323,428 research outputs found
Braham, E, NX23600
No full textThis record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/373222Surname: BRAHAM
Given Name(s) or Initials: E
Military Service Number or Last Known Location: NX23600
Missing, Wounded and Prisoner of War Enquiry Card Index Number: 3104184262
Item: [2016.0049.05543] "Braham, E, NX23600
Braham-shorthorn cross bulls
No full textBraham-shorthorn cross bulls (first introduced into area), Wave Hill, on their way to Lansdowne, West Australia. Pat Quirk in background.Kettle, Ellen.Date:1954-0
Braham, F R, VX48320
No full textThis record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/373223Surname: BRAHAM
Given Name(s) or Initials: F R
Military Service Number or Last Known Location: VX48320
Missing, Wounded and Prisoner of War Enquiry Card Index Number: 38005184263
Item: [2016.0049.05544] "Braham, F R, VX48320
The death of Nelson [music] : recitative & song /
No full textD.& S. 4820 (Publisher number). No. 1 in C. For voice and piano.; Cover title.; Pl. no.: D.& S. 4820.; "No. 1 in C.".; Also available online http://nla.gov.au/nla.mus-vn3410504
Motor racing, tobacco company sponsorship, barcodes and alibi marketing
No full textBackground Sponsorship of Formula One (F1) motor racing, which has been used as an indirect medium of tobacco advertising for several decades, was prohibited by the 2005 European Union Tobacco Advertising Directive. Most F1 tobacco sponsorship of motor racing in the EU has since ceased, with the exception of the Scuderia Ferrari team, which continues to be funded by Philip Morris. In 2007, the Marlboro logo on Ferrari cars and other race regalia was replaced by an evolving ‘barcode’ design, which Ferrari later claimed was part of the livery of the car, and not a Marlboro advertisement.
Objective: To determine whether the ‘barcode’ graphics used by Ferrari represent ‘alibi’ Marlboro advertising.
Methods Academic and grey literature, and online tobacco industry document archives, were searched using terms relevant to tobacco marketing and motorsport.
Results Tobacco sponsorship of F1 motor racing began in 1968, and Philip Morris has sponsored F1 teams since 1972. Phillip Morris first used a ‘barcode’ design, comprising red vertical parallel lines below the word Marlboro on the British Racing Motors F1 car in 1972. Vertical or horizontal ‘barcode’ designs have been used in this way, latterly without the word Marlboro, ever since. The modern ‘barcode’ logos occupied the same position on cars and drivers' clothing as conventional Marlboro logos in the past. The shared use of red colour by Marlboro and Ferrari is also recognised by Philip Morris as a means of promoting brand association between Marlboro and Ferrari.
Conclusion The Ferrari ‘barcode’ designs are alibi Marlboro logos and hence constitute advertising prohibited by the 2005 EU Tobacco Advertising Directive
Mixed Marriage
No full textThis voice describes the phenomena of mixed marriages, evidencing the main concepts and aspects provided by the sociological, the psychological and the juridical perspectives. The voice is also available in the Italian version: see “Matrimoni misti”
Diffusive author(s), cohesive author: Analysis of S/N (1994)
No full textThis study indicates the ways in which various aspects of the author(s) are brought forth in Dumb type’s performance art, the S/N production. Previous research has suggested a non-hierarchical organization of Dumb type and the absence of a “privileged author” in Dumb type’s collaborative work, S/N. However, the results that I have investigated from member’s interviews on the creative process of S/N along with my analysis of the recorded images of S/N, indicate a different aspect of the author(s). First, S/N was created through, so to speak, the collective ideas of the members of Dumb type. Further, S/N has at least nine quotations from previous performances, installations, and printed writings, besides the work-in-progress technique. Explicating one of the “author functions” as given by Michel Foucault, each text has plural subjects of the author. However, it has been revealed from members’ interviews that Teiji Furuhashi had a decision-making role in selecting the members’ ideas within the performance. Since then, S/N has had plural subjects of creation; however, Furuhashi is one of the subjects of creation along with the “privileged author.” S/N has plural authors (diffusive authors) yet at the same time, it has a “privileged author,” Teiji Furuhashi (cohesive author)
Evaluation of a new PT-INR monitoring system in patients with the antiphospholipid syndrome
No full textIntroductionPatients on anticoagulant therapy with vitamin K antagonists (VKA) need frequent INR monitoring. Reliability of point-of-care (POC) devices for measuring INR needs rigorous evaluation, particularly in patient with the antiphospholipid syndrome (APS). The aim of this study was to evaluate the accuracy of the ProTime InRhythm System (here called device) for INR measurement in patients with APS on VKA.
MethodsWe compared the device INR vs. the laboratory INR measurement for blood samples from 29 APS-positive and 31 APS-negative patients consecutively enrolled. APS was confirmed by positive serological and/or phospholipid-dependent coagulation tests. Chromogenic factor X assay was used to evaluate anticoagulation. Bland-Altman difference plot for paired INR (POC vs. laboratory) was used to evaluate agreement between the device and the laboratory. The device INR relationship with factor X chromogenic assay was evaluated by orthogonal regression analysis.
ResultsOverall, 97% of the device INR measurements were similar to laboratory INR values with an absolute difference less than 0.4 units. Correlation coefficient for the device INR vs. factor X was -0.69 (P < 0.0001, CI 95% -0.80 to -0.52).
ConclusionsThe ProTime InRhythm System is an accurate point-of-care device for measuring INR also in patients with and without APS
- …
